California
How Association for Molecular Pathology v. Myriad Genetics, Inc. applies in California: state-specific rules, key cases, and bar exam notes for Intellectual Property (Patent Law).
California adheres to similar principles as established in Myriad, emphasizing that mere discovery of a natural product does not warrant patent protection. The state's law reinforces the balance between innovation and public access to genetic information.
In California, as in Myriad, naturally occurring DNA sequences are not patentable, aligning with the broader interpretation under federal law that prohibits claims solely on nature.
The court emphasized that inventions must involve significant human modification of natural substances to qualify for patent protection.
This case confirmed the limitations on patenting natural products and genetic materials, aligning with the principles established in Myriad.
Reaffirmed that human genes are products of nature and not patentable, influencing state interpretations of intellectual property rights.
California's approach reflects the federal standard as articulated in Myriad, maintaining a strong stance against the patentability of natural genes. However, California courts may further elaborate on distinctions related to biotechnological inventions that integrate natural products with human ingenuity.
This case is crucial for California bar examinees, particularly in understanding genetic patenting and the scope of intellectual property in biotechnology.